IP Library Granted Patent US 11,237,157
Granted Patent B2
US 11,237,157 · App. 16/861,040 · Granted Feb 1, 2022

Reagent and method for assaying thrombin-antithrombin complex

Inventors: Tatsuya Yoshida (Tokyo, JP); Yuhang Yang (Tokyo, JP)
Assignee: LSI MEDIENCE CORPORATION
G01N33/54333G01N33/53G01N33/5306G01N33/543G01N33/54353G01N2333/974
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,237,157
App. No.
16/861,040
Granted
Feb 1, 2022
Kind
B2
Abstract

A method for measuring TAT complexes in a sample separated from a living body includes measuring TAT by performing latex immunoagglutination reaction under a condition of pH 5.8 to 6.6 using a TAT assay reagent. The TAT assay reagent includes a first antibody bound to a first latex particle, which binds to the antithrombin part of the TAT complex and recognizes the complex, and a second antibody bound to a second latex particle, which binds to the thrombin part of the TAT complex and recognizes the complex.

Claims (6)

1. A method for measuring (T)-antithrombin (AT) (TAT) complexes in a sample separated from a living body, comprising:

(a) performing a latex immunoagglutination reaction under an acidic condition of pH 5.8 to 6.6, comprising contacting the sample with a latex agglutination assay reagent wherein the latex agglutination assay reagent comprises:

(i) a first antibody bound to a first latex particle, wherein the first antibody binds to the antithrombin part of the TAT complex and recognizes the complex, wherein the first antibody has a reactivity to the TAT complex that is 100 to 50,000 times higher than the reactivity to from antithrombin, and (ii) a second antibody bound to a second latex particle wherein the second antibody binds to the thrombin part of the TAT complex and recognizes the complex; and

(b) measuring agglutination of latex particles formed by the reaction of the TAT complex, first antibody of (i) and the second antibody of (ii), thereby determining the amount of TAT complexes in the sample.

2. The method according to claim 1 , wherein said condition is pH of 6.0 to 6.4.

3. The method according to claim 1 , further comprising: contacting the sample with a first reagent comprising a buffer solution at a pH of 5.8 to 6.6 to form a mixture prior to step (a), and wherein performing the latex immunoagglutination reaction under an acidic condition of pH 5.8 to 6.6, comprises contacting the mixture comprising the sample and the first reagent with latex agglutination assay reagent.

Assignments (3)
CHANGE OF ADDRESS Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 066674/0958 →
COMPANY SPLIT Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: PHC CORPORATION
Reel/Frame 066675/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2020
From: YOSHIDA, TATSUYA; YANG, YUHANG
To: LSI MEDIENCE CORPORATION
Reel/Frame 053229/0389 →
Priority Claims (2)
JP 2015-074168 · Mar 31, 2015 · national
JP 2015-074173 · Mar 31, 2015 · national
Continuity (2)
Division 15562839
Related Publication 20200256864A1 · Aug 13, 2020